Last updated: 19 November 2026
Can you take CBD with antipsychotics such as olanzapine, risperidone or aripiprazole? Only if your specialist team agrees first: your psychiatrist or mental health team, then your GP or pharmacist. The BNF lists extra drowsiness with all three. CBD also blocks enzymes that clear them in lab tests, and no study has tested CBD supplements with any of them.
Below: what the BNF, NHS and product information say, the liver enzyme questions, drowsiness, THC, when to get help and what to ask. Never stop or change an antipsychotic to try CBD. This is general information, not medical advice.
Can you take CBD with antipsychotics?
Nobody can promise it is safe. CBD supplements have not been tested with olanzapine, risperidone or aripiprazole, so the risk is unknown, and the team who prescribe your medicine are best placed to weigh it up.
iThe NHS says these prescription medicines are used for conditions such as schizophrenia and bipolar disorder. Ask your psychiatrist or community mental health team first, then your GP or community pharmacist.
iThe Food Standards Agency (FSA) advises, as a precaution, that people taking any medication should not use CBD unless under medical direction. The NHS pages for all three ask you to tell your doctor or pharmacist about any supplements.
Related guides: CBD and quetiapine, CBD and lithium, CBD and lamotrigine and can CBD interact with medication? Caring for someone with dementia who also takes an antipsychotic? See CBD and dementia medication.
What the BNF and NHS and product information say
Checked at source on 19 November 2026:
| Source | What it says | What it means for you |
|---|---|---|
| BNF cannabidiol interactions | Olanzapine, risperidone and aripiprazole are each listed: both can cause sedation, which might affect skilled tasks such as driving | Expect more drowsiness than either alone |
| Zyprexa (olanzapine) product information | Olanzapine is broken down by CYP1A2; a lower dose should be considered if a CYP1A2 blocker is started | Anything that slows CYP1A2 matters |
| Risperidone and Abilify product information | Both are cleared mainly by CYP2D6, with CYP3A4; strong blockers raise levels | Anything that slows CYP2D6 matters |
| Epidyolex product information | Prescription CBD is a weak CYP1A2 blocker in people; it did not change a CYP3A4 test medicine | Some effects are proven, others lab-only |
The BNF, the reference UK prescribers use, gives the same drowsiness entry for other antipsychotics too, including clozapine, haloperidol, amisulpride and paliperidone.
Olanzapine and CBD: the CYP1A2 question
The Zyprexa product information says olanzapine is broken down by the liver enzyme CYP1A2. With fluvoxamine, a CYP1A2 blocker, olanzapine levels rose by 52% to 108%, and a lower olanzapine dose should be considered if a CYP1A2 blocker is started.
Where does CBD fit?
- In people. The Epidyolex product information says prescription CBD at 750mg twice a day nearly doubled blood levels of caffeine (a 95% rise), a standard CYP1A2 test substance. It calls CBD a weak CYP1A2 blocker and says similar modest rises may happen with other medicines cleared this way. Olanzapine was not tested.
- In the lab. CBD blocked CYP1 enzymes, including CYP1A2 (Yamaori and colleagues, 2010).
That study used 1,500mg of CBD a day, 150 times the FSA’s advised 10mg, and nobody has measured olanzapine with CBD. A small effect is possible but unproven. The Zyprexa product information also says smoking speeds up olanzapine’s breakdown, so mention any change in smoking too.
Risperidone and aripiprazole: the CYP2D6 question
Both rely on the liver enzyme CYP2D6:
- Risperidone. The product information says it is mainly broken down by CYP2D6, and less by CYP3A4. Strong CYP2D6 blockers such as fluoxetine and paroxetine raise its levels. It is also carried by a transporter called P-gp.
- Aripiprazole. The Abilify product information says a strong CYP2D6 blocker raised its levels by 107% and a strong CYP3A4 blocker by 63%, and that the dose should be cut to about half with strong blockers.
What is known about CBD:
- CYP2D6. CBD strongly blocked CYP2D6 in a 2011 lab study (Yamaori and colleagues). No study in people is reported.
- CYP3A4. Prescription CBD did not change midazolam, a CYP3A4 test medicine, in people.
- P-gp. The Epidyolex product information says CBD raised everolimus levels about 2.5 times, probably via P-gp in the gut, and other P-gp medicines may be affected. Risperidone was not tested.
So, as with olanzapine: possible, unmeasured in people, and a question for your prescriber. See also CBD and antidepressants.
Drowsiness and alcohol and driving
- Drowsiness. The NHS lists feeling sleepy as a common side effect of all three. The Epidyolex product information lists drowsiness as one of the most common side effects of prescription CBD, says alcohol and other sedating medicines add to it, and says it has a major influence on the ability to drive.
- Alcohol. The NHS says it’s best not to drink alcohol in the first days of olanzapine or risperidone, or with aripiprazole. More in CBD and alcohol.
- Driving. The NHS says don’t drive, cycle or use machinery if these medicines make you sleepy or dizzy. See CBD and driving.
Sleeping tablets, gabapentin and pregabalin stack on top: see CBD and sleeping tablets and CBD with gabapentin or pregabalin.
THC and psychosis: why the product matters
CBD and THC are different substances from the cannabis plant.
- Royal College of Psychiatrists. People who use cannabis have an increased risk of developing psychosis, more so when they start young or use stronger cannabis or use it regularly. THC is the only chemical in recreational cannabis shown to have psychoactive effects.
- NHS. Using drugs, particularly cannabis, can increase the risk of schizophrenia or psychosis, and in people who have had psychosis before, using drugs can cause a relapse. It adds that cannabis products bought online without a prescription have a good chance of containing THC.
So the product matters. If you take an antipsychotic, don’t use cannabis or any product whose contents you can’t be sure of, and show your team the label and lab certificate of any CBD product before you start. See CBD vs THC.
CBD sold in shops is a food supplement, not a medicine. It is not a treatment for psychosis, schizophrenia, bipolar disorder or any mental health condition.
Never stop or change an antipsychotic yourself
Keep taking your medicine as prescribed. The NHS says don’t stop olanzapine or aripiprazole suddenly, and that your doctor will usually reduce the dose of any of the three gradually if you need to stop, to avoid withdrawal symptoms.
CBD can’t replace an antipsychotic or let you take less. Any change to your treatment must come from your mental health team.
When to get help
Call 999 or go to A&E if someone’s life is at risk, if you don’t feel you can keep yourself safe, or if you have signs of a serious allergic reaction such as swollen lips, mouth, throat or tongue.
Call your doctor or NHS 111 now if you suddenly become very confused, drowsy or dizzy. The NHS lists this as a reason to get help on olanzapine or risperidone.
If you’ve recently started CBD, stop it, keep taking your antipsychotic as prescribed and tell whoever you speak to.
Support lines (checked 19 November 2026):
- Samaritans: call 116 123, free, any time, day or night.
- England: call NHS 111 and select the mental health option for urgent mental health help.
- Wales: call NHS 111 and press 2, 24 hours a day, 7 days a week.
- Scotland: call NHS 24 on 111 and choose the mental health option.
- Emergency: 999 or your nearest A&E.
Questions for your mental health team
iAsk your psychiatrist or mental health team first, then your GP or pharmacist, taking your medicine list and a photo of the CBD label:
- Is CBD reasonable with my antipsychotic, dose and other medicines, or should I avoid it?
- Could it change my medicine levels?
- Which side effects should make me stop the CBD and call you?
If you take several mental health medicines, ask about all of them at once.
Sources 12
- BNF (NICE). Cannabidiol interactions. Checked 19 November 2026.
- NHS. Olanzapine (reviewed 19 February 2025), Risperidone (reviewed 15 April 2025), Aripiprazole (reviewed 6 November 2026). Checked 19 November 2026.
- emc. Zyprexa 5 mg tablets: SmPC (sections 4.2, 4.5, 4.7, 5.2). Revised 9 April 2026; checked 19 November 2026.
- emc. Risperidone 1mg tablets: SmPC (sections 4.5, 4.7, 5.2). Revised 7 November 2021; checked 19 November 2026.
- emc. Abilify 10 mg tablets: SmPC (sections 4.2, 4.5, 4.7, 5.2). Revised 10 April 2026; checked 19 November 2026.
- emc. Epidyolex 100 mg/ml oral solution: SmPC (sections 4.4, 4.5, 4.7). Revised 8 June 2026; checked 19 November 2026.
- Royal College of Psychiatrists. Cannabis and mental health. Published December 2024; checked 19 November 2026.
- NHS. Schizophrenia: causes (last reviewed 13 April 2023) and Medical cannabis (last reviewed 27 May 2022). Checked 19 November 2026.
- Yamaori S et al. Cannabidiol and cannabinol as inhibitors of human CYP1 enzymes. Biochem Pharmacol, 2010. PMID 20117100.
- Yamaori S et al. Cannabidiol as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos, 2011. PMID 21821735.
- Food Standards Agency (GOV.UK). Cannabidiol (CBD) guidance. Updated 28 August 2026; checked 19 November 2026.
- Support lines: Samaritans; NHS: where to get urgent help for mental health; NHS 111 Wales press 2; NHS 24 mental health services. All checked 19 November 2026.
General information, not medical advice. Evopure makes CBD food supplements, and we don’t recommend starting CBD alongside an antipsychotic without your specialist team’s OK. For more, see can CBD interact with medication? and CBD side effects. Evopure is not connected with the makers of any medicine named here.





































